Research Journal of Topical and Cosmetic Sciences

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Some Aspects of Drug Delivery Through Nail: A Review


Affiliations
1 Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur (Raj.), India
     

   Subscribe/Renew Journal


The nail is horny structure. Nail plate is responsible for penetration of drug across it. As it is hard enough the penetration becomes difficult, only a fraction of topical drug penetrates across it. Various nail diseases can be cured by achieving desired therapeutic concentration of drug by nail drug delivery system. Oral therapies are accompanied by systemic side effects and drug interactions, while topical therapies are limited by the low permeation rate through the nail plate. For the successful treatment of nail disease the applied active drug must permeate through the dense keratinized nail plate and reach deeper layers, the nail bed and the nail matrix. The purpose of this review is to highlight the understanding of physicochemical parameters that influence drug permeation through the nail plate in order to treat not only topical nail diseases but also to consider the possibility to reach systemic circulation and neighboring target sites.

Keywords

Nail, Drug Delivery System, Therapeutic, Topical Application.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Dykyj J. D. Anatomy of the nail. Clin Padiatr Med Surgery. 6(2); 1989: 521-28.

  • Baden HP, Goldsmith LA, Fleming B. A comparative study of the physicochemical properties of human keratinized tissues. Biochim Biophys Acta. 322; 1973: 269–278.

  • Zaias N.M.D., Alvarez J. The formation of the primate nails plate. An autoradiographic study in squirrel monkey. J Invest Dermatol. 51(2); Aug 1968: 120-136.

  • Dawber R.P.R., de Berker D.A.R., Baran R. Science of the nail apparaturs. In: Baran R., Dawber R.P.R., de Berker D.A.R., Haneke E., Tosti A. (Ed.), Baran and Dawber’s Diseases of the nails and their management. Blackwell Scientific Publications, Oxford (UK). 2001; pp. 1-47.

  • Murdan S. Drug delivery to the nail following topical application. International Journal of Pharmaceutics. 236(1-2); 2002: 1-26.

  • Achten G., Andre J., Laporte M. Nails in light and electron microscopy. Semin. Dermatol. 10(1); March 1991: 54-64.

  • Murdan S. Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Deliv. 5(11); 2008: 1267-1282.

  • Dawber R.P.R., Baran R. Structure, embryology, comparative anatomy and physiology of the nail. In: Baran R., Dawber R.P.R. (Ed.). Diseases of the nails and their management. Blackwell Scientific Publications, Oxford (UK). 1984: pp. 1-23.

  • Kobayashi Y., Miyamoto M., Sugibayashi K., Morimoto Y. Drug permeation through the three layers of the human nail plate. Journal of Pharmacy and Pharmacology. 51(3); 1999: 271- 278.

  • Walters K.A., Flynn G.L. Permeability characteristics of the human nail plate. Intrnational J Cosmetic Science 5(6); 1983: 231-246.

  • Baran R. and Dawber R.P.R. Diseases of the nails and their management. Blackwell Scientific Publication, Oxford and Boston. 1994; 2nd ed: pp. 345-415.

  • Sau P et.al. Bowen’s disease of the nail bed and periungnal area. Arch Dermatol. 130; 1994: 204.

  • Debruyne D. and Coquerel A. Pharmacokinetics of antifungal agents in onychomycoses. Clin Pharmacokinet. 40(6); 2001: 441-472.

  • Drake L.A., Scher R.K., Smith E.B., Faich G.A., Smith S.L., Hong J.J., Stiller M.J. Effect of onychomycosis on quality of life. J Am Acad Dermatol. 38(5); 1998: 702-704.

  • Lubeck D.P. Measuring health-related quality of life in onychomycosis. J Am Acad Dermatol. 38; 1998: 64-68.

  • Ghannoum M.A., Hajjeh R.A., Scher R., Konnikov N., Gupta A.K., Summerbell R., Sullivan S., Daniel R., Krusinski P., Fleckman P., Rich P., Odom R., Aly R., Pariser D., Zaiac M., Rebell G., Lesher J., Gerlach B., Ponce-de-Leon G.F., Ghannoum A., Warner J., Isham N., Elwski B. A large-scale North American study of fungal isolates from nails: the frequency of nychomycosis, fungal distribution, and fungal susceptibility patterns. J Am Acad Dermatol. 43(4); Oct 2000: 641-648.

  • Dawber R.P.R., Baran R. Fungal (onychomycosis) and other infections of the nail apparatus. In: Baran R., Dawber R.P.R. (Ed.). Diseases of the nails and their management. Blackwell Scientific Publications, Oxford (UK). 1984a: pp. 121-156.

  • Lawry M., Rich P. The nail apparatus: a guide for basic and clinical science. Curr. Probl. Dermatol. 11(5); 1999: 161-208.

  • Rodgers P., Bassler M. Treating onychomycosis. Am Fam Physician. 63(4); 2001: 663-672.

  • Gauri M, Joel L., Zatz. Investigation of nail permeation enhancement by chemical modification. J Pharm Sci. 91(2); 2002: 312-323.

  • Soong M.H. Transport properties of drugs and model compounds across the human nail. Ph.D. Dissertation. University of Minnesota. 1991.

  • Larry E. Millikan. Drug Therapy in Dermatology. CRC Press. 2000.

  • De Doncker P. Pharmacokinetics of orally administered antifungals in onychomycosis. Int J Dermatol. 38 (Suppl. 2); 1999: 20-27.

  • Gupta A.K., Ryder J.E. The use of oral antifungal agents to treat onychomycosis. Dermatol Clin. 21(3); 2003: 469-479.

  • Gupta A.K., Tu L.Q. Therapies for onychomycosis: a review. Dermatol Clin. 24(3); 2006: 375-379.

  • Gauwerky K., Borelli C., Korting H.C. Targeting virulence: a new paradigm for antifungals. Drug Discov Today. 14(3-4); 2009: 214-222.

  • Kobayashi Y., Komatsu T., Sumi M., Numajiri M., Miyamoto D., Kobayashi K., Sugibayashi K., Morimoto Y. In vitro permeation of several drugs through the human nail plate: Relationship between physicochemical properties and Nail permeability of drugs. Eur J Pharm Sci. 21; 2004: 471-477.

  • Gunt H.B., Kasting G.B. Effect of hydration on the permeation of ketoconazole through human nail plate in vitro. Eur J Pharm Sci. 32(4-5); 2007: 254-260.

  • Khengar R.H., Jones S.A., Turner R.B., Forbes B., Brown M.B. Nail swelling as a pre-formulation screen for the selection and optimization of ungula penetration enhancers. Pharm Res. 24; 2007: 2207-2212.

  • Nair A.B., Sammeta S.M., Kim H.D., Chakraborty B., Friden P.M., Murthy S.N. Alternation of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation. Int J Pharm. 375; 2009: 22-27.

  • Boker A., Burks J. Can a new nail trephination device help treat nail conditions? Pod. Today. 20(11); 2007: 34-36.

  • Malhotra G.G., Zatz J.L. Investigation of nail permeation enhancement by chemical modification using water as a probe. J Pharm Sci. 91 (2); 2001: 312-323.

  • Brown M.B., Khengar R.H., Turner R.B., Forbes B., Traynor M.J., Evans C.R.G., Jones S.A. Overcoming the nail barrier: A systematic investigation of ungula chemical penetration enhancement. Int. J Pharm. 370; 2009: 61-67.

  • Murthy S.N., Waddell D.C., Shivkumar H.N., Balaji A. and Bowers C.P. “Iontophoretic permselective property of human nail”. Journal of Dermatological Science. 46(2); 2007: 150-152.

  • Walters K.A., Flynn G.L. and Marvel J.R. “Physicochemical characterization of the human nail: Solvent effect on the permeation of homologous alcohols”. Journal of Pharmacy and Pharmacology. 37; 1985: 771-775.

  • Mertin D. and Lippold B.C. “In-vitro permeability of human nail and of a keratin membrane from Bovine Hooves: Influence of partition coefficient octanol/water and the water solubility of drugs on their permeability and maximum flux”. Journal of Pharmacy and Pharmacology. 49(9); 1997: 30-34.

  • Kenneth A., Walters, Gordon L., Flynn and John R. Marvel. Physiochemical characterization of the human nail. J Pharm Pharmacol. 35(1); 1983: 28-33.


Abstract Views: 835

PDF Views: 0




  • Some Aspects of Drug Delivery Through Nail: A Review

Abstract Views: 835  |  PDF Views: 0

Authors

S. Panchawat
Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur (Raj.), India

Abstract


The nail is horny structure. Nail plate is responsible for penetration of drug across it. As it is hard enough the penetration becomes difficult, only a fraction of topical drug penetrates across it. Various nail diseases can be cured by achieving desired therapeutic concentration of drug by nail drug delivery system. Oral therapies are accompanied by systemic side effects and drug interactions, while topical therapies are limited by the low permeation rate through the nail plate. For the successful treatment of nail disease the applied active drug must permeate through the dense keratinized nail plate and reach deeper layers, the nail bed and the nail matrix. The purpose of this review is to highlight the understanding of physicochemical parameters that influence drug permeation through the nail plate in order to treat not only topical nail diseases but also to consider the possibility to reach systemic circulation and neighboring target sites.

Keywords


Nail, Drug Delivery System, Therapeutic, Topical Application.

References